News Search Results
Apr 29, 2025, 08:34 ET AlphaRose Therapeutics Announces Acquisition of Alpha Anomeric SA, a French Company with Industry-Leading Oligonucleotide Technology
April 29, 2025 /PRNewswire/ -- AlphaRose Therapeutics, an advanced preclinical-stage biotechnology company focused on developing and commercializing therapeutics for neurogenetic developmental diseases, today announces the acquisition of Alpha
More news about: AlphaRose Therapeutics
Apr 29, 2025, 08:24 ET Tavo Biotherapeutics Announces Appointment of Seasoned Executives to Key Posts
Development Officer, and Graham Cooper as Chief Financial Officer. Both bring proven track records of success in the biotechnology industry. "I am thrilled to bring on Lukas and Graham to Tavo's senior team," said Gary Berman, Chief Executive
More news about: Tavo Biotherapeutics
Apr 29, 2025, 08:05 ET INOVIO to Report First Quarter 2025 Financial Results on May 13, 2025
MEETING, Pa., April 29, 2025 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancers, and infectious
More news about: INOVIO Pharmaceuticals, Inc.
Apr 29, 2025, 08:05 ET Rigel Announces Conference Call and Webcast to Report First Quarter 2025 Financial Results and Business Update
via the Rigel website. About RigelRigel Pharmaceuticals, Inc. (Nasdaq: RIGL) is a biotechnology company dedicated to discovering, developing and providing novel therapies that significantly improve the lives of patients with hematologic disorders
More news about: Rigel Pharmaceuticals, Inc.
Apr 29, 2025, 08:02 ET GreenLight Biosciences Announces Breakthrough in RNA Herbicide Development, Advancing More Sustainable Weed Control
April 29, 2025 /PRNewswire/ -- GreenLight Biosciences (the Company or GreenLight Bio), a pioneering agricultural biotechnology company, today announced a significant breakthrough in its bioherbicide development pipeline.
More news about: GreenLight Biosciences
Apr 29, 2025, 08:00 ET Flagship Pioneering Appoints Rahul Kakkar as CEO-Partner and CEO of Quotient Therapeutics
physician-scientist with nearly 20 years of professional experience founding and building biotechnology companies and practicing medicine. Previously, he served as President and CEO of Tome Biosciences, a genome engineering biotechnology platform company. Prior to Tome, Dr. Kakkar was CEO at Pandion Therapeutics,
More news about: Flagship Pioneering
Apr 29, 2025, 08:00 ET Curis to Report First Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on May 6, 2025
Mass., April 29, 2025 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 inhibitor, today announced that the Company
More news about: Curis, Inc.
Apr 29, 2025, 07:30 ET Dynavax Highlights Superior Board Leadership Overseeing Long-Term Value Creation Strategy
Total stockholder returns of 267% over the past five years: Far exceeding the performance of the NASDAQ Biotechnology Index and the S&P Biotechnology Select Industry Index1.Highly successful commercialization of HEPLISAV-B®: Generated
More news about: Dynavax Technologies
Apr 29, 2025, 07:30 ET Palatin Announces Breakthrough Symptom Resolution in Updated Analyses from Phase 3 PL9643 MELODY-1 Clinical Trial in Dry Eye Disease
complete clinical trials and submit applications for regulatory approvals, products developed by competing pharmaceutical, biopharmaceutical and biotechnology companies, commercial acceptance of Palatin's products, and other factors discussed in Palatin's periodic filings with the Securities and Exchange
More news about: Palatin Technologies, Inc.
Apr 29, 2025, 07:00 ET ScaleReady Announces March Biosciences as Recipient of G-Rex® Grant to Advance Manufacturing of Novel CAR-T Cell Therapy
MB-105, the progress of clinical trials for pipeline candidates, regulatory approvals, market demand for new therapies, competitive dynamics in the biotechnology sector, and macroeconomic conditions.
More news about: Bio-Techne Corporation
Apr 29, 2025, 06:15 ET Epson Advances SCARA Performance with New GX-C Series Robots
of experience, Epson Robots delivers robots for precision assembly and material handling applications in the aerospace, appliance, automotive, biotechnology, consumer product, electronics, food processing, medical device, pharmaceutical, plastics, semiconductor, and telecommunication industries. For
More news about: Epson America, Inc.
Apr 29, 2025, 06:15 ET Epson Robots to Showcase New High-Performance Automation Solutions and SafeSense Technology at Automate 2025
of experience, Epson Robots delivers robots for precision assembly and material handling applications in the aerospace, appliance, automotive, biotechnology, consumer product, electronics, food processing, medical device, pharmaceutical, plastics, semiconductor, and telecommunication industries. For
More news about: Epson America, Inc.
Apr 29, 2025, 06:00 ET Stealth BioTherapeutics Announces Delay in FDA Action Date for Barth Syndrome Application
April 29, 2025 /PRNewswire/ -- Stealth BioTherapeutics Inc. (the "Company" or "Stealth"), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving mitochondrial dysfunction, today announced
More news about: Stealth BioTherapeutics Inc.
Apr 29, 2025, 05:45 ET Shareholders that lost money on Sana Biotechnology, Inc.(SANA) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
April 29, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Sana Biotechnology, Inc. ("Sana Biotechnology, Inc." or the "Company") (NASDAQ: SANA) of a class action securities lawsuit.
More news about: Levi & Korsinsky, LLP
Apr 28, 2025, 21:00 ET Amorepacific Research Confirms Potential of Microalgal-Derived PDRNs in Skin Regeneration and Wound Healing
also observed in skin tissue with epidermal damage caused by photoaging, as demonstrated in experiments conducted by Outer Biosciences Inc., a biotechnology company in Boston, MA, USA that researches ingredients for skin health. Byung-Fhy
More news about: Amorepacific
Apr 28, 2025, 20:05 ET INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Sana Biotechnology, Inc. and Certain Officers - SANA
April 28, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Sana Biotechnology, Inc. ("Sana" or the "Company") (NASDAQ: SANA) and certain officers. The class action, filed in the United States
More news about: Pomerantz LLP
Apr 28, 2025, 18:55 ET Heron Therapeutics Announces Appointment of Mark Hensley as Chief Operating Officer
April 28, 2025 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX) ("Heron" or the "Company"), a commercial-stage biotechnology company, today announced the appointment of Mark Hensley as Chief Operating Officer. Mr. Hensley has more than fifteen years of experience in a
More news about: Heron Therapeutics, Inc.
Apr 28, 2025, 16:01 ET AMGEN ANNOUNCES WEBCAST OF 2025 FIRST QUARTER FINANCIAL RESULTS
to help millions of patients in their fight against some of the world's toughest diseases. More than 40 years ago, Amgen helped to establish the biotechnology industry and remains on the cutting-edge of innovation, using technology and human genetic data to push beyond what's known today. Amgen is advancing
More news about: Amgen
Apr 28, 2025, 14:58 ET WACKER showcases binder technology for nonwoven products and solutions at IDEA2025
industries include healthcare, pharmaceuticals, cosmetics, construction, automotive, and food/nutrition. WACKER is a pioneer in silicone, polymer, and biotechnology solutions and the leading provider of polysilicon for semiconductor and solar applications. Media Contact:James
More news about: Wacker Chemical Corporation
Apr 28, 2025, 14:38 ET Prominent Life Sciences Partner Rejoins Latham's Bay Area Offices
firm's fantastic Healthcare & Life Sciences Practice," said Hillier. "Latham's unmatched global platform, depth of expertise in private equity, biotechnology, life sciences and healthcare, and collaborative culture provide the perfect environment for me to continue delivering exceptional service to clients
More news about: Latham & Watkins LLP
Apr 28, 2025, 14:15 ET INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Sana Biotechnology, Inc. and Certain Officers - SANA
April 28, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Sana Biotechnology, Inc. ("Sana" or the "Company") (NASDAQ: SANA) and certain officers. The class action, filed in the United States
More news about: Pomerantz LLP
Apr 28, 2025, 14:00 ET Myosin Therapeutics Awarded $3 Million NIH Grant to Advance Clinical Trial for MT-110 in Methamphetamine Use Disorder
Fla., April 28, 2025 /PRNewswire/ -- Myosin Therapeutics, Inc., a biotechnology company developing innovative therapies for cancer and neurological disorders, today announced that it has been awarded a $3
More news about: Myosin Therapeutics Inc.
Apr 28, 2025, 13:35 ET SANA Investors Have Opportunity to Lead Sana Biotechnology, Inc. Securities Fraud Lawsuit
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Sana Biotechnology, Inc. (NASDAQ: SANA) between March 17, 2023 and November 4, 2024, both dates inclusive
More news about: THE ROSEN LAW FIRM, P. A.
Apr 28, 2025, 12:02 ET Rubin and Rudman Partner Jason Webber Named a 2025 "Go To Construction Lawyer" by Massachusetts Lawyers Weekly
Rubin and Rudman serves national and international companies, including large public companies and closely held businesses; real estate developers; biotechnology, pharmaceutical and medical device makers; regulated industries, public entities and municipalities; insurance companies and their insureds; educational
More news about: Rubin and Rudman
Apr 28, 2025, 10:30 ET Live Cell Imaging Market worth US$4.75 billion in 2030 with 8.68% CAGR | MarketsandMarkets™
growth is supported by the increasing investments in healthcare infrastructure, rising government support for life science research, and expanding biotechnology and pharmaceutical industries that are pushing the demand for advanced imaging technologies. India, China,
More news about: MarketsandMarkets